By bringing together the nation's leading hospitals and their regional clinics, we want to establish a national pipeline for evaluating new therapies. Informed by evidence-based research, our aim is to quickly and efficiently deliver real answers about what supports work, when these supports need to be given, and for which people they are best for.
ND Australia is an endorsed member of the Australian Clinical Trials Alliance (ACTA) that supports quality, investigator- initiated trials in the Australian health system.
Neurodevelopment Clinical Trials
The Australian Clinical Trials Alliance is the national peak body supporting and representing networks of clinician researchers in the Australian healthcare system.
This includes supporting:
researchers conducting investigator-initiated clinical trials;
clinical quality registries and;
clinical trial coordinating centres
These are a few of the Clinical Trials being conducted in our leading universities and hospitals and they're looking for your help!
Every 15 hours an Australian baby is born with cerebral palsy. Despite confidence in early intervention, 50% don’t receive intervention before their first birthday while awaiting diagnosis. We have promising data about a new brain training intervention (GAME) that harnesses a child's developing brain and improves movement. 300 infants receive either early brain training, or Standard Care alone.
We are comparing whether or not the early brain training delivers any benefits over and above Standard Care. Babies with, or at high-risk of, cerebral palsy, will participate from 3-24 months of age. This study involves sites from NSW, VIC, WA and QLD.
This project aims to increase knowledge on factors influencing the outcome of childhood and adolescent mental disorders and to improve outcomes by investigating treatment strategies for families in which both parents and children suffer from mental health symptoms.
The University of Sydney's Autism Clinic for Translational Research is running multiple trials looking at the effectiveness of a new nasal spray in reducing social and behavioural difficulties in children with Autism. Oxytocin, a naturally occurring hormone in the brain (also known as the love hormone). They are currently recruiting suitable candidates
Researchers at Monash University are engaged in a range of projects directly addressing the causes and treatment of autism spectrum disorders (ASDs). Current projects include, applying DNA sequencing technology to identify novel risk genes for ASD. Cognitive training to improve memory. As well as applying brain imaging technologies to understand the wiring of the brain in both health and disorder. Brain imaging of individuals with ASD offers the hope of finding neurological markers that may aid diagnosis.